The key actions needed to end AIDS are relatively clear. The question is whether every government, funder, and implementing organisations will apply them.
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they’re available to all.
The HIV epidemic is far from over and it’s not time to disengage, says International Aids Society President Linda-Gail Bekker.